Menin-Inhibitor Targeted Maintenance in AML

Clinical trial NCT07563010 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07563010
Sponsor: Center for International Blood and Marrow Transplant Research
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Adult AML Stem Cell Transplant Complications Acute Myeloid Leukemia Transplant-Related Hematologic Malignancy

Start date: 2026-12-01
Primary completion: 2031-06-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.